RecallDepth
Class II Terminated

Valsartan Tablets, USP 40 mg Rx Only NDC 50268-783-15 50 Tablets (5x10) Unit Dose Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Company
Avkare Inc.
Recall Initiated
August 14, 2018
Posted
September 5, 2018
Recall Number
D-1130-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6776 cartons (338,800 tablets)
Firm Location
Pulaski, TN, United States

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Distribution

U.S. Nationwide

Lot / Code Info

Lots: 18491 Exp. 10/2018; 19531 Exp. 04/2019; 20168 Exp. 05/2019; 20671 Exp. 08/2019; 21049 Exp. 10/2019; 21635 Exp. 10/2019

More recalls by Avkare Inc.

View all recalls by this company →

Other recent Class II Drug recalls